Clinical Trials Logo

Clinical Trial Summary

This study is a multicenter, open label, observational, post marketing surveillance study of NutropinAq® in Austria, France, Germany, Italy, Spain, Romania and United Kingdom to collect long-term safety and effectiveness information on NutropinAq® during treatment of paediatric growth disorders.


Clinical Trial Description

The objective of this study is to collect long term safety and effectiveness information on Ipsen's growth hormone (GH) NutropinAq® regarding treatment of paediatric growth disorders for which GH is indicated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00455728
Study type Observational
Source Ipsen
Contact
Status Completed
Phase
Start date June 2006
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT00455884 - A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency